scispace - formally typeset
L

Louise Evenden

Researcher at University of Edinburgh

Publications -  5
Citations -  441

Louise Evenden is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Gene & DNA methylation. The author has an hindex of 4, co-authored 4 publications receiving 342 citations. Previous affiliations of Louise Evenden include Western General Hospital.

Papers
More filters
Journal ArticleDOI

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease

Nicholas T. Ventham, +107 more
TL;DR: Site-specific DNA methylation changes in IBD relate to underlying genotype and associate with cell-specific alteration in gene expression, andSeparated cell data shows that IBD-associated hypermethylation within the TXK promoter region negatively correlates with gene expression in whole-blood and CD8+ T cells, but not other cell types.
Journal ArticleDOI

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases

TL;DR: associated levels of IgG Fc-glycosylation with disease (compared to controls) and its clinical features could increase the understanding of mechanisms of CD and UC pathogenesis and be used to develop diagnostics or guide treatment.
Journal ArticleDOI

Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936.

TL;DR: Gene Ontology enrichment analysis indicated an enrichment of biological processes involved in the immune system in smokers compared to non-smokers and the expression of transcripts for genes previously associated with stress response, autoimmune disease and cancer were associated with telomere length.
Journal ArticleDOI

Genome-wide methylation profiling in 229 patients with Crohn's disease requiring intestinal resection: Epigenetic analysis of the Trial of prevention of post-operative Crohn's disease (TOPPIC).

Nicholas T. Ventham, +97 more
TL;DR: The TOPPIC trial as discussed by the authors was a placebo-controlled, randomized controlled trial of 6-mercaptopurine at 29 UK centers in patients with Crohn's disease recurrence following intestinal resection between 2008 and 2012.